Background: Although a molecular diagnosis is possible in most patients having Charcot-Marie-Tooth disease (CMT), recessively inherited and axonal neuropathies still present a diagnostic challenge.
T HE PAST DECADE HAS SEEN major advances in our understanding of the causes of inherited neuropathies. Duplication of the PMP22 (peripheral myelin protein 22) gene and point mutations in GJB1 (gap junction protein, beta 1) and MPZ (peripheral myelin protein zero) account for approximately 85% of unselected cases, but a growing number of genes have been implicated in the remaining 15% of patients, affecting a diverse group of cellular processes ranging from axonal transport to DNA repair. 1 The central role of mitochondria in maintaining peripheral nerve integrity is an emerging theme, as illustrated by pathogenic mutations in MFN2 (mitofusin 2) and DNM2 (dynamin 2) that disrupt organelle fusion and fission. 1 Although axonal neuropathies are well recognized in patients having classic multisystem mitochondrial disease, isolated neuropathy is uncommon. 2 Herein, we describe a family manifesting an autosomal recessive axonal sensorimotor neuropathy that dominated the clinical phenotype for more than 2 decades. This was due to compound heterozygous mutations in the POLG1 gene, which codes for mitochondrial DNA (mtDNA) polymerase ␥.
REPORT OF A CASE
A 35-year-old man had manifested abnormal gait and pes cavus at age 10 years. When initially seen at age 22 years, his main symptoms were reduced dexterity and sensory disturbance affecting his face, hands, and feet. Findings on physical examination disclosed that he had marked bilateral distal weakness and wasting of the small muscles of the forearms, hands, calves, and feet. His proximal power was normal. There was clawing of the toes on the left foot and minimal tremor of the outstretched hands. Joint position and vibration sense were lost in the toes of both feet. Nerve conduction studies revealed an axonal sensorimotor neuropathy consistent with Charcot-Marie-Tooth disease type 2 (CMT2) ( Table) . He subsequently developed progressive, predominantly distal muscle wasting and a postural tremor at age 33 years, followed by dysarthria.
Neurological examination at age 35 years (a video is available at http://www .archneurol.com) disclosed that he had a He was the product of a nonconsanguineous union, with healthy parents aged 63 and 61 years. His 40-year-old brother (II-2) was also initially diagnosed as having CMT2 (Table) but had a less severe clinical course. His 42-yearold sister (II-4) developed similar symptoms at age 9 years, was diagnosed as having CMT2 in her early 20s, and is now unable to walk, with severe ataxia (a video is available at http://www.archneurol.com). A 41-year-old brother (II-3) was clinically unaffected. Three half-siblings of the father (data not shown) remain unaffected.
Video available online at www.archneurol.com
Results of routine blood tests in the proband were normal. Cerebrospinal fluid examination results were unremarkable, except for an elevated lactate level (21.5 mg/dL [to convert to millimoles per liter, multiply by 0.111]). Brain magnetic resonance imaging, echocardiography, and pure-tone audiometry findings were normal. Neuropsychometry revealed no major deficits. Results of genetic testing for chromosome 17 duplication, PMP22, MPZ, and spinocerebellar ataxia types 1, 2, 3, 6, and 7 expansions were negative. A nerve biopsy speci-men revealed epineural fibrosis but no evidence of inflammation or amyloid.
RESULTS
Muscle histochemistry findings were consistent with ongoing denervation and reinnervation, with fiber-type grouping. There was a mosaic defect of cytochrome c oxidase affecting 6% of muscle fibers (Figure 1A) . Longrange polymerase chain reaction of skeletal muscle DNA revealed multiple deletions of mtDNA ( Figure 1B) . POLG1 sequencing revealed the following 3 heterozygous substitutions in the proband: c.191CϾT in exon 2, c.695GϾA in exon 3, and c.2209GϾC in exon 13. Segregation analysis in the family (Figure 2) showed that the c.191CϾT and c.695GϾA substitutions were in cis and inherited from the mother and that the c.2209GϾC substitution was inherited from the father. The affected brother (II-2) had the same genotype as that of the proband. The unaffected brother (II-3) had a wild-type sequence.
The frequency of the POLG1 substitutions was determined by primer extension and by matrix-assisted laser 
